Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exagen Inc (NQ: XGN )

1.780 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 1.780
Bid (Size) 1.510 (5)
Ask (Size) 1.950 (5)
Prev. Close 1.780
Today's Range 1.780 - 1.780
52wk Range 1.300 - 3.043
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
From Exagen Inc.
Via GlobeNewswire

Performance

YTD
-9.64%
-9.64%
1 Month
-9.64%
-9.64%
3 Month
+17.88%
+17.88%
6 Month
-9.64%
-9.64%
1 Year
-39.25%
-39.25%

More News

Read More
Exagen Announces Campaign for Lupus Awareness Month
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce First Quarter 2024 Results on May 13, 2024
From Exagen Inc.
Via GlobeNewswire
Earnings Outlook For Exagen
Via Benzinga
Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29
Via Investor Brand Network
Earnings Preview For Exagen
Via Benzinga
Exagen Inc. Announces Changes to the Board of Directors
From Exagen Inc.
Via GlobeNewswire
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Via Benzinga
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Exagen Inc. Reports Strong Third Quarter 2023 Results
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For November 13, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.